In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Abbott buys remaining stake of Ibis for $175mm plus earn-outs

Executive Summary

Abbott, which last January had paid $40mm for an 18.6% stake in Isis Pharmaceuticals' Ibis Biosciences subsidiary, is now buying the rest of the unit for another $175mm in cash. Abbott will also pay future earn-outs based on sales of Ibis's instruments and assay kits through 2025.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
  • Research, Analytical Equipment & Supplies
Deal Status
  • Final
Deal Type
  • Acquisition
    • Includes Earnout
    • Partial Acquisition
    • Payment Includes Cash

Related Companies